Latest: Excel Industries Ltd Q1 FY27 results →All Q2 FY26 results →
E

Excel Industries Ltd

Q2 FY26Chemicals & Petrochemicals

Excel Industries Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Price₹1,089
Market cap₹1.3K Cr
P/E17.9
Updated23 Aug 2026
Read4 min read

The short version

Current capacity utilization is 70% to 75%, with effective maximum utilization around 85% to 90% due to operational flexibility and maintenance. Excel Industries targets full-year EBITDA margins of 13% to 15% for FY26, reflecting stable profitability despite Q3 being a lean quarter.

From Excel Industries Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Current capacity utilization is 70% to 75%, with effective maximum utilization around 85% to 90% due to operational flexibility and maintenance.
  • Existing assets offer headroom for volume growth without immediate need for major expansion.
  • New CAPEX of approximately Rs 200-300 crores planned over next 3 years, including Rs 35-40 crores for a long-term specialty chemical contract manufacturing project expected to generate Rs 35-40 crores in annual revenue.
  • Incremental revenue expected from newly commissioned biocide capacity (~Rs 15 crores annual revenue) and other contract manufacturing projects (~Rs 10-12 crores), with combined potential incremental revenue around Rs 60 crore at peak.

2 more points from Excel Industries Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Excel Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Excel Industries plans total CAPEX of Rs 200-300 crores over the next three years, covering both maintenance and growth.
  • Recently signed a long-term 5-year contract manufacturing deal requiring Rs 40 crores investment for a dedicated production line, commissioning expected by June 2026.
  • Commissioned a capacity expansion for a key biocide product in October 2025 with Rs 10.33 crores invested; full-year revenue expected at Rs 15 crores.
  • Ongoing debottlenecking and modernization CAPEX of around Rs 35-40 crores excluding raw materials, staggered over 12-18 months, covering multiple projects.

2 more points from Excel Industries Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Excel Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Some relevant points related to contracts and future business are: - Signed a binding term sheet for a long-term contract manufacturing arrangement spanning five years with a specialty chemicals company. - New dedicated production line associated with this contract expected to be commissioned by June 2026. - Estimated investment for this project is Rs 40 crores, with expected annual revenue of Rs 35-40 crores (excluding raw materials), EBITDA accretive. - Recently commissioned capacity expansion for a key biocide product; initial supplies under a long-term supply contract have commenced.

2 more points from Excel Industries Ltd's call on order book

Create a free account to keep reading this call

Excel Industries Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹281 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Gujarat Alkalies (Q2 FY26)

    2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against

  • Dynemic Products Ltd (Q2 FY26)

    Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a

  • Platinum Industries Ltd (Q2 FY26)

    Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri

  • IVP Ltd (Q2 FY26)

    Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Excel Industries Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Excel Industries Ltd Q2 FY26 results?

Current capacity utilization is 70% to 75%, with effective maximum utilization around 85% to 90% due to operational flexibility and maintenance. Excel Industries targets full-year EBITDA margins of 13% to 15% for FY26, reflecting stable profitability despite Q3 being a lean quarter.

What is Excel Industries Ltd share price analysis?

Excel Industries Ltd currently shows a neutral. The stock trades at a P/E of 17.9 with a market cap of ₹1,274 Cr. Investors should review the full earnings analysis for detailed insights.

Is Excel Industries Ltd planning capital expenditure?

Excel Industries plans total CAPEX of Rs 200-300 crores over the next three years, covering both maintenance and growth.

Keep Excel Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.